Optiflow™ in Practice

 

Facebook LinkedIn YouTube Twitter
Optiflow™ Nasal High Flow at the Royal Berkshire Hospital

Introducing Optiflow to the Royal Berkshire Hospital - a multi-department implementation

Explore Optiflow in practice. This video shows the usage of AIRVO 2 and Optiflow High Flow therapy in different departments of the Royal Berkshire Hospital in Reading, UK. It shows the benefits they have found both to the patients and hospital since its introduction.

(3 minutes long)
Find out more about Optiflow
Post-Extubation video

Extubating to
Optiflow NHF therapy

This video depicts extubation to Optiflow NHF therapy, and is based on the procedure used by Dr. Hernández and his colleagues' in the following studies:
1. Hernández et al. JAMA. 2016 (April) and
2. Hernández et al. JAMA. 2016 (Oct.) 

Webinar focused
on home use of
Nasal High Flow
in patients with
chronic disease

Associate Professor Ulla Møller Weinreich speaks about
her research on humidified high flow therapy for patients
with chronic disease in this Nasal High Flow webinar.
 

Primary Outcome (intention to treat analysis)

Primary outcome of humidified high flow therapy for patients graph


Exacerbation rates (of chronic disease) were significantly lower in patients in the NHF + long term oxygen therapy (LTOT) group compared with the LTOT only group

Storgaard LH, Hockey HU, Laursen BS, Weinreich UM. Long–term effects of oxygen–enriched high–flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis. 2018; 13:1195–205.

 

 

Optiflow newsletter – Flow Matters

Keep up to date with the latest in Optiflow HF therapy clinical research.

Go With Flow - Issue 8

Issue 8 

(440 kb PDF)
 
First published clinical protocol detailing the application of High Flow therapy for adult patients with acute hypoxemic respiratory failure.
Go With The Flow Issue 7

Issue 7 

(315 kb PDF)
 
 Optiflow post extubation. Using Optiflow to reduce the risk of reintubation.
 
Go With The Flow Issue 7

Issue 6

(315kb PDF)
High flow therapy compared with conventional oxygen therapy and NIV.

Follow us on Twitter

If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.
Contact Details
Please select from the following options:*

Enter security code
 Security code
By submitting this form, you consent to Fisher & Paykel Healthcare storing your personal information to contact you about your enquiry. Your information will be collected and stored securely by Fisher & Paykel Healthcare Limited based in New Zealand and may be shared with the wider Fisher & Paykel Healthcare group as necessary to support your enquiry. We will not share, disclose or sell your information to third parties for marketing purposes. For full details on how we use and manage your personal information, how long we may retain this information for sales or marketing purposes, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.